Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HUMALOG LISPRO, NPL: 109 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
109
Total FAERS Reports
6 (5.5%)
Deaths Reported
47
Hospitalizations
109
As Primary/Secondary Suspect
3
Life-Threatening
6
Disabilities

First Report: 1998 · Latest Report: 20140605

What Are the Most Common HUMALOG LISPRO, NPL Side Effects?

#1 Most Reported
Blood glucose increased
26 reports (23.9%)
#2 Most Reported
Hypoglycaemia
9 reports (8.3%)
#3 Most Reported
Wrong drug administered
8 reports (7.3%)

All HUMALOG LISPRO, NPL Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Blood glucose increased 26 23.9% 0 13
Hypoglycaemia 9 8.3% 1 6
Dyspnoea 8 7.3% 1 5
Incorrect dose administered 8 7.3% 0 3
Malaise 8 7.3% 0 4
Visual impairment 8 7.3% 0 3
Wrong drug administered 8 7.3% 0 8
Blood glucose decreased 7 6.4% 0 2
Drug dose omission 7 6.4% 0 1
Maternal exposure during pregnancy 7 6.4% 0 3
Fall 6 5.5% 0 5
Visual acuity reduced 6 5.5% 0 2
Blindness 5 4.6% 0 0
Glycosylated haemoglobin increased 5 4.6% 0 4

Who Reports HUMALOG LISPRO, NPL Side Effects? Age & Gender Data

Average age: 56.6 years. Most reports from: US. View detailed demographics →

Is HUMALOG LISPRO, NPL Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 2 0 1
2004 1 0 0
2007 1 0 0
2008 1 1 1
2010 3 0 2
2011 3 0 3
2012 5 0 4
2013 17 0 9
2014 20 0 12

View full timeline →

What Is HUMALOG LISPRO, NPL Used For?

IndicationReports
Type 2 diabetes mellitus 44
Diabetes mellitus 32
Product used for unknown indication 17
Gestational diabetes 7
Type 1 diabetes mellitus 7

HUMALOG LISPRO, NPL vs Alternatives: Which Is Safer?

HUMALOG LISPRO, NPL vs HUMAN C1-ESTERASE INHIBITOR HUMALOG LISPRO, NPL vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX HUMALOG LISPRO, NPL vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN HUMALOG LISPRO, NPL vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN HUMALOG LISPRO, NPL vs HUMAN IMMUNOGLOBULIN G HUMALOG LISPRO, NPL vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE HUMALOG LISPRO, NPL vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN HUMALOG LISPRO, NPL vs HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE, RECOMBINANT HUMALOG LISPRO, NPL vs HUMAN RABIES VIRUS IMMUNE GLOBULIN HUMALOG LISPRO, NPL vs HUMAN RHO IMMUNE GLOBULIN

Official FDA Label for HUMALOG LISPRO, NPL

Official prescribing information from the FDA-approved drug label.